Calliditas Therapeutics AB
STO:CALTX

Watchlist Manager

Calliditas Therapeutics AB

STO:CALTX

Watchlist

Dividends

Price: 208 SEK 0.87% Market Closed

Market Cap: 11.2B SEK

Have any thoughts about
Calliditas Therapeutics AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Fubotv Inc NYSE:FUBO	Media
US	Bank of America Corp NYSE:BAC	Banking
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Uber Technologies Inc NYSE:UBER	Road & Rail
CN	NIO Inc NYSE:NIO	Automobiles
US	Fluor Corp NYSE:FLR	Construction
US	Jacobs Engineering Group Inc NYSE:J	Professional Services
US	TopBuild Corp NYSE:BLD	Consumer products
US	Abbott Laboratories NYSE:ABT	Health Care
US	Chevron Corp NYSE:CVX	Energy
US	Occidental Petroleum Corp NYSE:OXY	Energy
US	Matrix Service Co NASDAQ:MTRX	Construction
US	Automatic Data Processing Inc NASDAQ:ADP	Technology
US	Qualcomm Inc NASDAQ:QCOM	Semiconductors
US	PayPal Holdings Inc NASDAQ:PYPL	Technology
US	Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 208 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

CALTX Alert

Calliditas Therapeutics AB

208

+1.8 (+0.87%)

52 Week Range	86.45 208.2
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	PayPal Holdings Inc NASDAQ:PYPL	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Calliditas Therapeutics AB

What unique competitive advantages
does Calliditas Therapeutics AB hold over its rivals?

What risks and challenges
does Calliditas Therapeutics AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Calliditas Therapeutics AB.

What unique competitive advantages
does Calliditas Therapeutics AB hold over its rivals?

What risks and challenges
does Calliditas Therapeutics AB face in the near future?

Has there been any significant insider trading activity
in Calliditas Therapeutics AB recently?

Summarize the latest earnings call
of Calliditas Therapeutics AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Calliditas Therapeutics AB.

Provide P/S
for Calliditas Therapeutics AB.

Provide P/E
for Calliditas Therapeutics AB.

Provide P/OCF
for Calliditas Therapeutics AB.

Provide P/FCFE
for Calliditas Therapeutics AB.

Provide P/B
for Calliditas Therapeutics AB.

Provide EV/S
for Calliditas Therapeutics AB.

Provide EV/GP
for Calliditas Therapeutics AB.

Provide EV/EBITDA
for Calliditas Therapeutics AB.

Provide EV/EBIT
for Calliditas Therapeutics AB.

Provide EV/OCF
for Calliditas Therapeutics AB.

Provide EV/FCFF
for Calliditas Therapeutics AB.

Provide EV/IC
for Calliditas Therapeutics AB.

Show me price targets
for Calliditas Therapeutics AB made by professional analysts.

What are the Revenue projections
for Calliditas Therapeutics AB?

How accurate were the past Revenue estimates
for Calliditas Therapeutics AB?

What are the Net Income projections
for Calliditas Therapeutics AB?

How accurate were the past Net Income estimates
for Calliditas Therapeutics AB?

What are the EPS projections
for Calliditas Therapeutics AB?

How accurate were the past EPS estimates
for Calliditas Therapeutics AB?

What are the EBIT projections
for Calliditas Therapeutics AB?

How accurate were the past EBIT estimates
for Calliditas Therapeutics AB?

Compare the revenue forecasts
for Calliditas Therapeutics AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Calliditas Therapeutics AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Calliditas Therapeutics AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Calliditas Therapeutics AB compared to its peers.

Compare the P/E ratios
of Calliditas Therapeutics AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Calliditas Therapeutics AB with its peers.

Analyze the financial leverage
of Calliditas Therapeutics AB compared to its main competitors.

Show all profitability ratios
for Calliditas Therapeutics AB.

Provide ROE
for Calliditas Therapeutics AB.

Provide ROA
for Calliditas Therapeutics AB.

Provide ROIC
for Calliditas Therapeutics AB.

Provide ROCE
for Calliditas Therapeutics AB.

Provide Gross Margin
for Calliditas Therapeutics AB.

Provide Operating Margin
for Calliditas Therapeutics AB.

Provide Net Margin
for Calliditas Therapeutics AB.

Provide FCF Margin
for Calliditas Therapeutics AB.

Show all solvency ratios
for Calliditas Therapeutics AB.

Provide D/E Ratio
for Calliditas Therapeutics AB.

Provide D/A Ratio
for Calliditas Therapeutics AB.

Provide Interest Coverage Ratio
for Calliditas Therapeutics AB.

Provide Altman Z-Score Ratio
for Calliditas Therapeutics AB.

Provide Quick Ratio
for Calliditas Therapeutics AB.

Provide Current Ratio
for Calliditas Therapeutics AB.

Provide Cash Ratio
for Calliditas Therapeutics AB.

What is the historical Revenue growth
over the last 5 years for Calliditas Therapeutics AB?

What is the historical Net Income growth
over the last 5 years for Calliditas Therapeutics AB?

What is the current Free Cash Flow
of Calliditas Therapeutics AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Calliditas Therapeutics AB.

CALTX

Income Statement

Operating Expenses

Calliditas Therapeutics AB
Operating Expenses

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Calliditas Therapeutics AB
Operating Expenses Peer Comparison

Comparables:

CAMX

SECARE

IRLAB A

MOB

FLERIE

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company		Operating Expenses	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Calliditas Therapeutics AB STO:CALTX	Operating Expenses -kr1.8B	CAGR 3-Years -50%	CAGR 5-Years -61%	CAGR 10-Years N/A
	Camurus AB STO:CAMX	Operating Expenses -kr1.2B	CAGR 3-Years -27%	CAGR 5-Years -25%	CAGR 10-Years N/A
S	Swedencare AB (publ) STO:SECARE	Operating Expenses -kr1.2B	CAGR 3-Years -87%	CAGR 5-Years -88%	CAGR 10-Years N/A
	IRLAB Therapeutics AB STO:IRLAB A	Operating Expenses -kr58m	CAGR 3-Years -31%	CAGR 5-Years 5%	CAGR 10-Years N/A
	Moberg Pharma AB (publ) STO:MOB	Operating Expenses -kr27.5m	CAGR 3-Years 8%	CAGR 5-Years N/A	CAGR 10-Years N/A
I	InDex Pharmaceuticals Holding AB STO:FLERIE	Operating Expenses -kr111.9m	CAGR 3-Years -18%	CAGR 5-Years -9%	CAGR 10-Years N/A

What is Calliditas Therapeutics AB's Operating Expenses?

Operating Expenses
-1.8B SEK

Based on the financial report for Jun 30, 2024, Calliditas Therapeutics AB's Operating Expenses amounts to -1.8B SEK.

What is Calliditas Therapeutics AB's Operating Expenses growth rate?

Operating Expenses CAGR 5Y
-61%

Over the last year, the Operating Expenses growth was -35%. The average annual Operating Expenses growth rates for Calliditas Therapeutics AB have been -50% over the past three years , -61% over the past five years .

Calliditas Therapeutics AB
STO:CALTX

Calliditas Therapeutics AB
Operating Expenses

Calliditas Therapeutics AB
Operating Expenses Peer Comparison

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

See Also

What is Calliditas Therapeutics AB's Operating Expenses?

Operating Expenses
-1.8B SEK

What is Calliditas Therapeutics AB's Operating Expenses growth rate?

Operating Expenses CAGR 5Y
-61%

Company

Help

Tools

Stocks

Calliditas Therapeutics AB STO:CALTX

Calliditas Therapeutics AB Operating Expenses

Calliditas Therapeutics AB Operating Expenses Peer Comparison

Competitive Operating Expenses Analysis Latest Figures & CAGR of Competitors

See Also

What is Calliditas Therapeutics AB's Operating Expenses? Operating Expenses -1.8B SEK

What is Calliditas Therapeutics AB's Operating Expenses growth rate? Operating Expenses CAGR 5Y -61%

Company

Help

Tools

Stocks

Calliditas Therapeutics AB
STO:CALTX

Calliditas Therapeutics AB
Operating Expenses

Calliditas Therapeutics AB
Operating Expenses Peer Comparison

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

What is Calliditas Therapeutics AB's Operating Expenses?

Operating Expenses
-1.8B SEK

What is Calliditas Therapeutics AB's Operating Expenses growth rate?

Operating Expenses CAGR 5Y
-61%